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Background: Medical costs affect how patients seek care, yet little is known about their association with outcomes after hospitalization for acute 
myocardial infarction (MI).
Methods: PREMIER, a registry of MI patients hospitalized at 19 US hospitals between 2002 - 2004, was used to examine the relationship between 
burden of medical costs and mortality, readmission, and health status. Patients (n=2412) characterized medical costs in the past year as no burden 
(B1), a low burden (B2) or a high burden (B3). All cause mortality and readmission were assessed at 4 year and 1 year, respectively. Health status 
at one year was assessed using the Seattle Angina Questionnaire angina frequency (SAQ-F) and Short Form-12 physical component scores (SF-12 
PCS). Cox proportional hazards, modified Poisson, and linear regression models adjusting for patient characteristics and site were used to assess the 
association of medical cost burden and outcomes.
Results: 1547 (64.1%) reported no burden, 393 (16.3%) reported low burden, and 472 (19.6%) reported high burden. Higher medical cost burden 
was associated with higher crude 4 year mortality (B1 16.5%, B2 19.9%, B3 21.4%, p=0.04) and crude 1 year readmission rate (B1 36.9%, B2 
42.3%, B3 47.5%, p<0.01). At one year, higher medical cost burden was associated with higher rate of reported angina (B1 16.4%, B2 22.2%, B3 
28.5%, p<0.01) and greater physical limitations by SF-12 PCS (B1 46.0, B2 43.9, B3 40.6, p<0.01). In multivariable analyses, medical cost burden 
was not associated with readmission (B1 hazard ratio [HR] 1.00 [ref]; B2 HR 1.01 95% confidence interval [CI] 0.82-1.24; B3 HR 1.10, 95% CI 
0.90-1.34), mortality (B1 HR 1.00 [ref]; B2 HR 1.08, 95% CI 0.80-1.47; B3 HR 1.23, 95% CI 0.94-1.64) or physical functioning (SF-12 PCS B1 
0.00 [ref]; B2 0.13, 95% CI -1.20,1.47; B3 -0.78, 95% CI -2.16,0.60). Medical cost burden, however, was associated with a greater risk of reporting 
angina (B1 relative risk [RR] 1.00 [ref]; B2 RR 1.17, 95% CI 1.02-1.34; B3 RR 1.33, 95% CI 1.07-1.65).
Conclusion: Patients reporting medical costs as a burden post-MI report more frequent angina, but are not at greater risk for poorer physical 
health status, readmission or mortality.
